These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1963023)

  • 1. Prevention of post-operative thromboembolism in general surgery with enoxaparin: preliminary findings.
    Haas S; Flosbach CW
    Acta Chir Scand Suppl; 1990; 556():96-102. PubMed ID: 1963023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of postoperative thromboembolism with Enoxaparin in general surgery: a German multicenter trial.
    Haas S; Flosbach CW
    Semin Thromb Hemost; 1993; 19 Suppl 1():164-73. PubMed ID: 8395721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
    Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H
    Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of thromboembolic disease in general surgery with enoxaparin (Clexane).
    Samama M; Combe S
    Acta Chir Scand Suppl; 1990; 556():91-5. PubMed ID: 1963022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of enoxaparin, a low-molecular-weight heparin, and unfractionated heparin, with or without dihydroergotamine, in abdominal hysterectomy.
    Kaaja R; Lehtovirta P; Venesmaa P; Kajanoja P; Halonen P; Gummerus M; Partanen S
    Eur J Obstet Gynecol Reprod Biol; 1992 Nov; 47(2):141-5. PubMed ID: 1333998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of postoperative venous thrombosis: a randomized trial comparing unfractionated heparin with low molecular weight heparin in patients undergoing total hip replacement.
    Planes A; Vochelle N; Mazas F; Mansat C; Zucman J; Landais A; Pascariello JC; Weill D; Butel J
    Thromb Haemost; 1988 Dec; 60(3):407-10. PubMed ID: 2853459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of a low-molecular-weight heparin and standard unfractionated heparin for prophylaxis of postoperative venous thromboembolism: European multicenter trial.
    Kakkar VV; Boeckl O; Boneu B; Bordenave L; Brehm OA; Brücke P; Coccheri S; Cohen AT; Galland F; Haas S; Jarrige J; Koppenhagen K; LeQuerrec A; Parraguette E; Prandoni P; Roder JD; Roos M; Rüschemeyer C; Siewert JR; Vinazzer H; Wenzel E
    World J Surg; 1997 Jan; 21(1):2-8; discussion 8-9. PubMed ID: 8943170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enoxaparin in the prevention of deep venous thrombosis after major surgery: multicentric study. The Italian Study Group.
    Gazzaniga GM; Angelini G; Pastorino G; Santoro E; Lucchini M; Dal Prà ML
    Int Surg; 1993; 78(3):271-5. PubMed ID: 8276557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An international multicentre study: Clivarin in the prevention of venous thromboembolism in patients undergoing general surgery. Report of the International Clivarin Assessment Group.
    Boneu B
    Blood Coagul Fibrinolysis; 1993 Dec; 4 Suppl 1():S21-2. PubMed ID: 8180325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low molecular weight heparin (enoxaparin) compared with unfractionated heparin in prophylaxis of deep venous thrombosis and pulmonary embolism in patients undergoing hip replacement.
    Avikainen V; von Bonsdorff H; Partio E; Kaira P; Hakkinen S; Usenius JP; Kaaja R
    Ann Chir Gynaecol; 1995; 84(1):85-90. PubMed ID: 7645915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Heparin-associated thrombocytopenia, thrombosis and embolism. Side effects of thromboembolism prevention with low molecular weight heparin enoxaparin?].
    Mohr VD; Lenz J
    Chirurg; 1991 Sep; 62(9):686-90. PubMed ID: 1660803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
    Kakkar VV; Howes J; Sharma V; Kadziola Z
    Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness and safety of the low-molecular-weight heparin CY 216 in the prevention of fatal pulmonary embolism and thromboembolic death in general surgery. A multicentre, double-blind, randomized, controlled clinical trial versus placebo (STEP). STEP Study Group.
    Pezzuoli G; Neri Serneri GG; Settembrini PG; Coggi G; Olivari N; Negri G; Codemo R; Galli G; Roveri S
    Haemostasis; 1990; 20 Suppl 1():193-204. PubMed ID: 1964662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antithromboembolic efficacy and safety of enoxaparin in general surgery. German multicentre trial.
    Haas S; Flosbach CW
    Eur J Surg Suppl; 1994; (571):37-43. PubMed ID: 7519088
    [No Abstract]   [Full Text] [Related]  

  • 15. Factor Xa inhibition: correlation between the plasma levels of anti-Xa activity and occurrence of thrombosis and haemorrhage.
    Leizorovicz A; Bara L; Samama MM; Haugh MC
    Haemostasis; 1993 Mar; 23 Suppl 1():89-98. PubMed ID: 8388357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multicenter randomized double-blind study of enoxaparin compared with unfractionated heparin in the prevention of venous thromboembolic disease in elderly in-patients bedridden for an acute medical illness. The Enoxaparin in Medicine Study Group.
    Bergmann JF; Neuhart E
    Thromb Haemost; 1996 Oct; 76(4):529-34. PubMed ID: 8902991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of deep vein thrombosis with low molecular-weight heparin in patients undergoing total hip replacement. A randomized trial. The German Hip Arthroplasty Trial (GHAT) Group.
    Arch Orthop Trauma Surg; 1992; 111(2):110-20. PubMed ID: 1314065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcutaneous low-molecular-weight heparin versus standard heparin and the prevention of thromboembolism in medical inpatients. The Heparin Study in Internal Medicine Group.
    Harenberg J; Roebruck P; Heene DL
    Haemostasis; 1996; 26(3):127-39. PubMed ID: 8738587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective randomized trial of low molecular weight heparin-DHE and conventional heparin-DHE (with acenocoumarol) in patients undergoing gynaecological surgery.
    Steiner RA; Keller K; Lüscher T; Schreiner WE
    Arch Gynecol Obstet; 1989; 244(3):141-50. PubMed ID: 2544152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of venous thromboembolism: unfractionated heparin or low molecular weight heparins?
    Agnelli G
    Haematologica; 1995; 80(2 Suppl):78-83. PubMed ID: 7628776
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.